Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Mariscal (Barcelona, Spain), L. Alserawan (Barcelona, Spain), I. Castellví (Barcelona, Spain), E. Ortiz (Barcelona, Spain), P. Peñacoba (Barcelona, Spain), T. Franco-Leyva (Barcelona, Spain), J. Tandaipán (Barcelona, Spain), L. Martínez-Martínez (Barcelona, Spain), H. Corominas (Barcelona, Spain), P. Domingo (Barcelona, Spain), C. Juárez (Barcelona, Spain), D. Castillo (Barcelona, Spain). Usefulness of GDF-15 as a biomarker of respiratory worsening in COVID-19 patients.. 673

Member's Comments

No comment yet.

Related content which might interest you: Predictive value of multiorgan imaging biomarkers for predicting exacerbations in COPD patients Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Copeptin – a marker for differential diagnosis between acute exacerbation of COPD and heart failure in patients with acute dyspnea Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021 Clinical assessment for identifying causes of acute respiratory failure in cancer patients Source: Eur Respir J 2013; 42: 435-443 Year: 2013 Prognostic value of high troponin levels in acute COPD attack patients with respiratory insufficiency Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Usefulness of procalcitonin as a marker of bacterial inflammation in patients with heart failure and suspected pneumonia in x-ray examination Source: Annual Congress 2010 - Respiratory system involvement in non-pulmonary disorders Year: 2010 Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Serum procalcitonin (PCT-Q) as a diagnostic tool for bacterial lower respiratory tract infection among COPD patients with acute exacerbation Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Clinical significance of aspergillus isolation from respiratory samples in severe COPD patients. Usefulness of Ascioglu‘s criteria Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008 Walking assessments as the predictor of acute respiratory failure in the interstitial lung disease patients. Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care Year: 2020 Prognostic implication of pulmonary hypertension in Doppler echocardiographic assessment in patients with acute respiratory distress syndrome Source: Annual Congress 2010 - Intensive care unit outcome Year: 2010 The value of early lactate clearance in evaluating the prognosis of patients with respiratory failure Source: Annual Congress 2009 - Respiratory physiology Year: 2009 Evaluation of a new cardiac arrhythmias predictor in patients with COPD Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018 Dyspnoea in patients receiving noninvasive ventilation for acute respiratory failure: prevalence, risk factors and prognostic impact Source: Eur Respir J, 52 (2) 1702637; 10.1183/13993003.02637-2017 Year: 2018 Clinical outcome of non-invasive ventilation in elderly COPD patients with acute respiratory failure Source: Annual Congress 2008 - Use of noninvasive ventilation in various conditions Year: 2008 Serum G-CSF is a non-invasive biomarker classifying bacterial/neutrophilic COPD exacerbations Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 Early pulmonary rehabilitation increases 6MWD and reduces CRP in hospitalized patients with severe AECOPD Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases Year: 2020 Usefulness of inflammatory markers: procalcitonin, neopterin, C-reactive protein and MR-proANP in the follow-up of patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008 Response to non-invasive ventilation as a predictor for mortality in patients with acute respiratory failure due to acute exacerbation of COPD Source: International Congress 2017 – Noninvasive ventilation for acute respiratory failure Year: 2017 Elevation of cardiac troponin-I predicts long-term mortality in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Increased serum endotoxin levels as biomarker in acute exacerbations of COPD. Source: International Congress 2018 – Biomarkers of COPD Year: 2018